Cresco Labs Inc.
Cresco Labs Inc. (CRLBF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRLBF · as of Jun 9, 2026
Key Statistics
Explore Cresco Labs Inc. Data
crlbf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
The CRLBF analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $5.50, representing +479.13% upside from the current price of $0.95.
Competitors & Peers
crlbf competitorsCRLBF
ABTI
AGYTF
AVCTF
BHHKF
HLOSFStock Performance
Full HistoryAbout Cresco Labs Inc.
Cresco Labs Inc. along with its various subsidiaries, is actively engaged in the cultivation, production, and sale of both medical and recreational cannabis products throughout the United States. The…
what is cresco labs inc. · crlbf stock overview · cresco labs inc. company profile · who is cresco labs inc. ceo · crlbf OTC · cresco labs inc. headquarters · cresco labs inc. business segments
About Stock Overview & Key Data
Cresco Labs Inc. (CRLBF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Dec 3, 2018. As of the latest trading session, CRLBF stock price is $0.95, with a market capitalization of $336.4M. The stock has returned +76.98% over the past 12 months and -22.79% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Cresco Labs Inc. stock is Buy, with an average 12-month price target of $5.50. In fiscal year 2025, Cresco Labs Inc. reported revenue of $667.3M and net income of -$142.5M. For detailed data — including Cresco Labs Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cresco Labs Inc. (CRLBF) stock price is $0.95. The stock is traded on OTC under the ticker symbol CRLBF. The 52-week range is $0.43 – $2.30.